JESSICA ROLLINS: Open Payments
NPI 1053867945 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,842 in 103 payments from 21 companies in 2025. Trend: 2023 $2,043 · 2024 $2,059 · 2025 $1,842
Food & beverage: $1,842
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $241 |
| GlaxoSmithKline, LLC. | 9 | $170 |
| AstraZeneca Pharmaceuticals LP | 10 | $166 |
| ABBVIE INC. | 9 | $159 |
| Sumitomo Pharma America, Inc. | 11 | $154 |
| Amgen Inc. | 8 | $153 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $135 |
| Lilly USA, LLC | 7 | $114 |
| Abbott Laboratories | 6 | $104 |
| INTUITIVE SURGICAL, INC. | 1 | $77 |
Products named: GEMTESA, Kerendia, KRYSTEXXA, AIRSUPRA, MOUNJARO, FREESTYLE LIBRE 3, AREXVY, Ozempic.
Industry payments across AL — which companies pay providers there.
